327 related articles for article (PubMed ID: 33389269)
1. Development, In Vitro and In Vivo Evaluation of Racecadotril Orodispersible Films for Pediatric Use.
Wang B; Yang L; Wang B; Luo C; Wang Y; Wang H; Chen F; Xiang X
AAPS PharmSciTech; 2021 Jan; 22(1):15. PubMed ID: 33389269
[TBL] [Abstract][Full Text] [Related]
2. Preparation, characterization and in vitro evaluation of a polyvinyl alcohol/sodium alginate based orodispersible film containing sildenafil citrate.
Shi LL; Xu WJ; Cao QR; Yang M; Cui JH
Pharmazie; 2014 May; 69(5):327-34. PubMed ID: 24855822
[TBL] [Abstract][Full Text] [Related]
3. Development of Polyvinyl Alcohol/Polyethylene Glycol Copolymer-based Orodispersible Films Loaded with Entecavir: Formulation and In vitro Characterization.
Wei T; Zhou BY; Wu XH; Liu XA; Huo MW; Huang XX; Shi LZ; Shi LL; Cao QR
Curr Drug Deliv; 2023 Oct; ():. PubMed ID: 37929732
[TBL] [Abstract][Full Text] [Related]
4. Prolonged release from orodispersible films by incorporation of diclofenac-loaded micropellets.
Speer I; Lenhart V; Preis M; Breitkreutz J
Int J Pharm; 2019 Jan; 554():149-160. PubMed ID: 30414477
[TBL] [Abstract][Full Text] [Related]
5. Hydroxypropyl Methylcellulose Orodispersible Film Containing Desloratadine for Geriatric Use: Formulation and Evaluation.
Al-Oran AYF; Yenilmez E
Antiinflamm Antiallergy Agents Med Chem; 2023; 22(2):79-91. PubMed ID: 37904551
[TBL] [Abstract][Full Text] [Related]
6. Anti-solvent Precipitation Method Coupled Electrospinning Process to Produce Poorly Water-Soluble Drug-Loaded Orodispersible Films.
Song Q; Guo X; Sun Y; Yang M
AAPS PharmSciTech; 2019 Aug; 20(7):273. PubMed ID: 31385126
[TBL] [Abstract][Full Text] [Related]
7. Prolonged drug release properties for orodispersible films by combining hot-melt extrusion and solvent casting methods.
Speer I; Preis M; Breitkreutz J
Eur J Pharm Biopharm; 2018 Aug; 129():66-73. PubMed ID: 29792911
[TBL] [Abstract][Full Text] [Related]
8. Orodispersible films in individualized pharmacotherapy: The development of a formulation for pharmacy preparations.
Visser JC; Woerdenbag HJ; Crediet S; Gerrits E; Lesschen MA; Hinrichs WLJ; Breitkreutz J; Frijlink HW
Int J Pharm; 2015 Jan; 478(1):155-163. PubMed ID: 25448577
[TBL] [Abstract][Full Text] [Related]
9. Increased drug load and polymer compatibility of bilayered orodispersible films.
Carolina Visser J; Weggemans OAF; Boosman RJ; Loos KU; Frijlink HW; Woerdenbag HJ
Eur J Pharm Sci; 2017 Sep; 107():183-190. PubMed ID: 28709911
[TBL] [Abstract][Full Text] [Related]
10. Formulation and in vitro characterization of novel sildenafil citrate-loaded polyvinyl alcohol-polyethylene glycol graft copolymer-based orally dissolving films.
Xu LL; Shi LL; Cao QR; Xu WJ; Cao Y; Zhu XY; Cui JH
Int J Pharm; 2014 Oct; 473(1-2):398-406. PubMed ID: 25079431
[TBL] [Abstract][Full Text] [Related]
11. Compounding and Characterization of Oral Disintegrating Films Containing Memantine Hydrochloride for Geriatrics.
Rofiq HM; Phang HC; Janakiraman AK; Chew YL; Uddin AH; Sarker ZI; Lee SK; Liew KB
Int J Pharm Compd; 2023; 27(6):512-521. PubMed ID: 38100669
[TBL] [Abstract][Full Text] [Related]
12. Development of orodispersible polymer films with focus on the solid state characterization of crystalline loperamide.
Woertz C; Kleinebudde P
Eur J Pharm Biopharm; 2015 Aug; 94():52-63. PubMed ID: 25976316
[TBL] [Abstract][Full Text] [Related]
13. Investigation of Patient-Centric 3D-Printed Orodispersible Films Containing Amorphous Aripiprazole.
Lee JH; Park C; Song IO; Lee BJ; Kang CY; Park JB
Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890191
[TBL] [Abstract][Full Text] [Related]
14. Continuous manufacturing and analytical characterization of fixed-dose, multilayer orodispersible films.
Thabet Y; Lunter D; Breitkreutz J
Eur J Pharm Sci; 2018 May; 117():236-244. PubMed ID: 29499348
[TBL] [Abstract][Full Text] [Related]
15. Mechanical characteristics of orally disintegrating films: Comparison of folding endurance and tensile properties.
Takeuchi Y; Ikeda N; Tahara K; Takeuchi H
Int J Pharm; 2020 Nov; 589():119876. PubMed ID: 32927004
[TBL] [Abstract][Full Text] [Related]
16. Comparative study on disintegration methods for oral film preparations.
Speer I; Steiner D; Thabet Y; Breitkreutz J; Kwade A
Eur J Pharm Biopharm; 2018 Nov; 132():50-61. PubMed ID: 30201569
[TBL] [Abstract][Full Text] [Related]
17. Cyclodextrin inclusion complex of racecadotril: effect of drug-β- cyclodextrin ratio and the method of complexation.
Semalty M; Panchpuri M; Singh D; Semalty A
Curr Drug Discov Technol; 2014 Jun; 11(2):154-61. PubMed ID: 24188445
[TBL] [Abstract][Full Text] [Related]
18. Quality by design approach for optimizing the formulation and physical properties of extemporaneously prepared orodispersible films.
Visser JC; Dohmen WM; Hinrichs WL; Breitkreutz J; Frijlink HW; Woerdenbag HJ
Int J Pharm; 2015 May; 485(1-2):70-6. PubMed ID: 25746737
[TBL] [Abstract][Full Text] [Related]
19. Neoteric Approach of Fluoxetine Laden Orodispersible Film for Non-compliant Pediatric Patients of Selective Mutism and Obsessive-compulsive Disorder.
Dad HA; Shabbir AS; Ali S; Mahmood T
Turk J Pharm Sci; 2021 Dec; 18(6):683-694. PubMed ID: 34978397
[TBL] [Abstract][Full Text] [Related]
20. Design of freeze-dried Soluplus/polyvinyl alcohol-based film for the oral delivery of an insoluble drug for the pediatric use.
Shamma R; Elkasabgy N
Drug Deliv; 2016; 23(2):489-99. PubMed ID: 24892631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
